Home / Services / Licensing

Licensing

Our specialist healthcare team, with backgrounds in the life sciences, understand the complexities of valuations and deal structures that are unique to licensing deals in pharma and biotech and are with our clients every step of the way.

We support clients with:

- In-licensing
- Out-licensing
- Co-development
- Co-commercialisation

Contact Us

Our Latest Deals

View All Deals
Jul 2022
has divested its API site in Rhode Island, USA, to
Read More
Jun 2022
A Kester Capital-backed company
has received investment from
Read More
Jun 2022
has been acquired by
A company backed by GTCR and The Carlyle Group
Read More
May 2022
A subsidiary of Servier
has divested its anti-LAG-3 monoclonal antibody to
A subsidiary of Sino Biopharmaceutical Limited
Read More
Mar 2022
has divested its Ringaskiddy, Ireland, manufacturing facility
Read More
Mar 2022
has divested its Boucherville, Canada manufacturing facility
Read More
Feb 2022
has received investment from
Read More
Jan 2022
has divested its API manufacturing site in Cramlington, UK, to
Read More
Nov 2021
has received investment from
Read More
Nov 2021
has invested in
company name confidential
Read More
View All Deals

CG Results. Great people creating great outcomes, together.

Meet The Team Join The Team

Latest Insights

View all
Reports
16th February 2023

Pharma Commercialisation Services Update – February 2023

Welcome to our latest update on the outsourced Pharma Commercialisation Services sector. In this report we will be reviewing deal activity across 2022 and taking a look forward to see what 2023 may hold for the sector. We hope that you enjoy this report and look forward to discussing the data and underlying themes with […]

Read More
Insights
5th December 2022

The end of the ecommerce boom or the start of a new era of innovation and digital disruption?

Katherine Hobbs, Director at CG Results and Neil Trickett Managing Director of E2X discuss the outlook for ecommerce and why, despite the headlines, they see opportunities for operators and investors across the sector over the next 18-24 months As Black Friday and Cyber Monday draw to a close, you could be forgiven for concluding that […]

Read More
Reports
23rd November 2022

Pharma Licensing – an introduction

We are pleased to share our introduction to Pharma Licensing. This guide provides an overview of both in and out-licensing as well as insights on what to anticipate during the process. We hope that you find this guide useful and look forward to discussing the underlying themes with you. Do get in touch! Click to […]

Read More